.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Citi
Cipla
QuintilesIMS
Fish and Richardson
UBS
Merck
Baxter
Daiichi Sankyo

Generated: September 23, 2017

DrugPatentWatch Database Preview

Alatrofloxacin mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for alatrofloxacin mesylate and what is the scope of alatrofloxacin mesylate patent protection?

Alatrofloxacin mesylate
is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: alatrofloxacin mesylate

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list18
Clinical Trials: see list516
Patent Applications: see list189
Drug Prices:see low prices
DailyMed Link:alatrofloxacin mesylate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-002Dec 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-001Dec 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: alatrofloxacin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-001Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-002Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-002Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-001Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-001Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-002Dec 18, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Dow
Argus Health
McKesson
Johnson and Johnson
Deloitte
Federal Trade Commission
Fish and Richardson
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot